Figure 3.
Figure 3. Effect of prognostic features on the clinical course of CLL. Rate of disease progression as assessed by the treatment-free time interval measured in months from diagnosis for (A) ZAP-70 mRNA expression, (B) IgVH mutation status, (C) CD38 protein expression with cutoff of 7%, and (D) CD38 protein expression with cutoff of 30%.

Effect of prognostic features on the clinical course of CLL. Rate of disease progression as assessed by the treatment-free time interval measured in months from diagnosis for (A) ZAP-70 mRNA expression, (B) IgVH mutation status, (C) CD38 protein expression with cutoff of 7%, and (D) CD38 protein expression with cutoff of 30%.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal